BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 35749576)

  • 1. The role of bacterial transport systems in the removal of host antimicrobial peptides in Gram-negative bacteria.
    Blair JMA; Zeth K; Bavro VN; Sancho-Vaello E
    FEMS Microbiol Rev; 2022 Nov; 46(6):. PubMed ID: 35749576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
    Blair JM; Richmond GE; Piddock LJ
    Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Peptides: Mechanisms of Action and Resistance.
    Bechinger B; Gorr SU
    J Dent Res; 2017 Mar; 96(3):254-260. PubMed ID: 27872334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AcrAB-TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanism.
    Jang S
    BMB Rep; 2023 Jun; 56(6):326-334. PubMed ID: 37254571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of efflux pumps ın antıbıotıc resıstance of gram negatıve rods.
    Başaran SN; Öksüz L
    Arch Microbiol; 2023 Apr; 205(5):192. PubMed ID: 37060362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial strategies of resistance to antimicrobial peptides.
    Joo HS; Fu CI; Otto M
    Philos Trans R Soc Lond B Biol Sci; 2016 May; 371(1695):. PubMed ID: 27160595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
    Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV
    ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bacterial efflux pump proteins in antibiotic resistance across microbial species.
    Kumawat M; Nabi B; Daswani M; Viquar I; Pal N; Sharma P; Tiwari S; Sarma DK; Shubham S; Kumar M
    Microb Pathog; 2023 Aug; 181():106182. PubMed ID: 37263448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hydrophobic trap-the Achilles heel of RND efflux pumps.
    Aron Z; Opperman TJ
    Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of efflux pumps in Gram-negative bacteria.
    Pagès JM; Masi M; Barbe J
    Trends Mol Med; 2005 Aug; 11(8):382-9. PubMed ID: 15996519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the Periplasmic Chaperone Skp and Mutations in the Efflux Pump AcrAB-TolC Play a Role in Acquired Resistance to Antimicrobial Peptides in
    Kapach G; Nuri R; Schmidt C; Danin A; Ferrera S; Savidor A; Gerlach RG; Shai Y
    Front Microbiol; 2020; 11():189. PubMed ID: 32210923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time dependent asymptotic analysis of the gene regulatory network of the AcrAB-TolC efflux pump system in gram-negative bacteria.
    Youlden GH; Ricci V; Wang-Kan X; Piddock LJV; Jabbari S; King JR
    J Math Biol; 2021 Mar; 82(4):31. PubMed ID: 33694073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity
    Sturge CR; Felder-Scott CF; Pifer R; Pybus C; Jain R; Geller BL; Greenberg DE
    ACS Infect Dis; 2019 Aug; 5(8):1446-1455. PubMed ID: 31119935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides.
    Nuri R; Shprung T; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3089-100. PubMed ID: 26051126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.